1-4 of 4
Stefan Kopf
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glucose Load Following Prolonged Fasting Increases Oxidative Stress– Linked Response in Individuals With Diabetic Complications

Ekaterina von Rauchhaupt, Claus Rodemer, Elisabeth Kliemank, Ruben Bulkescher, Marta Campos, Stefan Kopf, Thomas Fleming, Stephan Herzig, Peter P. Nawroth, Julia Szendroedi, Johanna Zemva, Alba Sulaj
Journal: Diabetes Care
Diabetes Care 2024;47(9):1584–1592
https://doi.org/10.2337/dc24-0209
Published: 21 June 2024
View article titled, Glucose Load Following Prolonged Fasting Increases Oxidative Stress– Linked Response in Individuals With Diabetic Complications
Open the PDF for Glucose Load Following Prolonged Fasting Increases Oxidative Stress– Linked Response in Individuals With Diabetic Complications in another window
Journal Articles

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

Sabine Kahl, Sofiya Gancheva, Klaus Straßburger, Christian Herder, Jürgen Machann, Hisayuki Katsuyama, Stefan Kabisch, Elena Henkel, Stefan Kopf, Merit Lagerpusch, Konstantinos Kantartzis, Yuliya Kupriyanova, Daniel Markgraf, Theresa van Gemert, Birgit Knebel, Martin F. Wolkersdorfer, Oliver Kuss, Jong-Hee Hwang, Stefan R. Bornstein, Christian Kasperk, Norbert Stefan, Andreas Pfeiffer, Andreas L. Birkenfeld, Michael Roden
Journal: Diabetes Care
Diabetes Care 2020;43(2):298–305
https://doi.org/10.2337/dc19-0641
Published: 20 September 2019
View article titled, Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Open the PDF for Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial in another window
Includes: Supplementary data
Journal Articles

Sustained Effects of a Mindfulness-Based Stress-Reduction Intervention in Type 2 Diabetic Patients: Design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-Study)

Mechthild Hartmann, MSC, Stefan Kopf, MD, Claudia Kircher, MD, Verena Faude-Lang, MD, Zdenka Djuric, MD, Florian Augstein, Hans-Christoph Friederich, MD, Meinhard Kieser, PHD, Angelika Bierhaus, PHD, Per M. Humpert, MD, Wolfgang Herzog, MD, Peter P. Nawroth, MD
Journal: Diabetes Care
Diabetes Care 2012;35(5):945–947
https://doi.org/10.2337/dc11-1343
Published: 11 April 2012
View article titled, Sustained Effects of a Mindfulness-Based Stress-Reduction Intervention in Type 2 Diabetic Patients: <subtitle>Design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-Study)</subtitle>
Open the PDF for Sustained Effects of a Mindfulness-Based Stress-Reduction Intervention in Type 2 Diabetic Patients: <subtitle>Design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-Study)</subtitle> in another window
Includes: Supplementary data
Journal Articles

Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes

Per M. Humpert, MD, Stefan Kopf, Zdenka Djuric, MD, Thoralf Wendt, MD, Michael Morcos, MD, Peter P. Nawroth, MD, Angelika Bierhaus, PHD
Journal: Diabetes Care
Diabetes Care 2006;29(5):1111–1113
https://doi.org/10.2337/dc05-2478
Published: 01 May 2006
View article titled, Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes
Open the PDF for Plasma sRAGE Is Independently Associated With Urinary Albumin Excretion in Type 2 Diabetes in another window